Expression of aldehyde dehydrogenase after neoadjuvant chemotherapy is associated with expression of hypoxia-inducible factors 1 and 2 alpha and predicts prognosis in locally advanced breast cancer (2013)
- Authors:
- USP affiliated authors: TIÉZZI, DANIEL GUIMARÃES - FMRP ; ANDRADE, JURANDYR MOREIRA DE - FMRP
- Unidade: FMRP
- DOI: 10.6061/clinics/2013(05)03
- Subjects: NEOPLASIAS; MAMA; QUIMIOTERAPIA; PROGNÓSTICO (FATORES)
- Language: Inglês
- Imprenta:
- Source:
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
TIEZZI, Daniel Guimarães et al. Expression of aldehyde dehydrogenase after neoadjuvant chemotherapy is associated with expression of hypoxia-inducible factors 1 and 2 alpha and predicts prognosis in locally advanced breast cancer. Clinics, v. 68, n. 5, p. 592-598, 2013Tradução . . Disponível em: https://doi.org/10.6061/clinics/2013(05)03. Acesso em: 12 fev. 2026. -
APA
Tiezzi, D. G., Clagnan, W. S., Mandarano, L. R. M., Sousa, C. B. de, Marana, H. R. C., Tiezzi, M. G., & Andrade, J. M. de. (2013). Expression of aldehyde dehydrogenase after neoadjuvant chemotherapy is associated with expression of hypoxia-inducible factors 1 and 2 alpha and predicts prognosis in locally advanced breast cancer. Clinics, 68( 5), 592-598. doi:10.6061/clinics/2013(05)03 -
NLM
Tiezzi DG, Clagnan WS, Mandarano LRM, Sousa CB de, Marana HRC, Tiezzi MG, Andrade JM de. Expression of aldehyde dehydrogenase after neoadjuvant chemotherapy is associated with expression of hypoxia-inducible factors 1 and 2 alpha and predicts prognosis in locally advanced breast cancer [Internet]. Clinics. 2013 ; 68( 5): 592-598.[citado 2026 fev. 12 ] Available from: https://doi.org/10.6061/clinics/2013(05)03 -
Vancouver
Tiezzi DG, Clagnan WS, Mandarano LRM, Sousa CB de, Marana HRC, Tiezzi MG, Andrade JM de. Expression of aldehyde dehydrogenase after neoadjuvant chemotherapy is associated with expression of hypoxia-inducible factors 1 and 2 alpha and predicts prognosis in locally advanced breast cancer [Internet]. Clinics. 2013 ; 68( 5): 592-598.[citado 2026 fev. 12 ] Available from: https://doi.org/10.6061/clinics/2013(05)03 - Development of new formulations of biologics: expectations, immunogenicity, and safety for subcutaneous trastuzumab
- Recurrence and survival after neoadjuvant chemotherapy for locally advanced cervical cancer is dependent on the pathological response
- Expression of hypoxia-inducible factor 1-'alfa' and vascular endothelial growth factor-C in locally advanced breast cancer patients
- Volume of breast tissue excised during breast-conserving surgery in patients undergoing preoperative systemic therapy
- Mouse renal 4T1 cell engraftment as a model to study the influence of hypoxia in breast cancer progression
- Clinical criteria as predictive factors of response to primary hormone therapy in locally advanced breast cancer
- Genetic profile analysis of tumor stem cells in locally advanced breast cancer
- Impact of surgical staging in locally advanced cervical cancer and subsequent chemotherapy
- Germ cells and mammary gland transcritome comparison generate a powerful gene expression profile that predicts breast cancer survival
- IL17 promotes mammary tumor progression by changing the behavior of tumor cells and eliciting tumorigenic neutrophils recruitment
Informações sobre o DOI: 10.6061/clinics/2013(05)03 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
002457740.pdf | Direct link |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
